Term: rituximab
IPA: ɹɪˈtʌk.sɪˌmæb

==English==
{{wp}}

===Alternative forms===
* {{alter|en|IDEC-C2B8}}

===Etymology===
From {{af|en||-tu-|-ximab|t2=tumor|t3=chimeric monoclonal antibody}}.

===Pronunciation===
* {{IPA|en|/ɹɪˈtʌk.sɪˌmæb/|a=GA}}

===Noun===
{{en-noun|-|s}}

# {{lb|en|pharmaceutical drug}} A [[chimeric]] [[monoclonal antibody]] (trademark ''Rituxan'') administered by [[intravenous]] [[injection]] especially to treat {{w|non-Hodgkin lymphoma}} and {{w|chronic lymphocytic leukemia}} by binding to the [[protein]] [[C